CD276 and head and neck squamous cell carcinoma: CD276, which is highly expressed on the surface of HNSCC cells, helps tumour stem cells evade immune surveillance; blocking CD276 significantly inhibits lymph node metastasis and enhances antitumour immunity (43, 48).